Credits Available: 5.00 AMA PRA Category 1 Credit™, ABIM MOC

Description: The Type 2 inflammatory response plays a key role in several conditions, including atopic dermatitis, eosinophilic esophagitis, and asthma. While these diseases may present differently, they share a common underlying pathway, creating opportunities for more targeted and effective treatments. Pediatricians are well versed in managing these conditions, and recognizing their interconnections can help optimize patient care.

Exciting advancements in treatment, including biologics and other innovative therapies, offer new hope for patients with more severe forms of Type 2 inflammatory diseases. While these treatments are typically initiated by subspecialists, pediatricians play a vital role in identifying patients who may benefit from these options and guiding them through the referral process.

This program will provide valuable insights into recognizing comorbidities, making informed treatment decisions, and ensuring timely referrals so that patients receive therapies that address the root cause of their disease, not just the symptoms.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Pediatrics

Jonathan Olsen

University of Utah
Assistant Clinical Professor

Jonathan Olsen specializes in allergy, asthma, and clinical immunology and see both children and adults in his practice. He is a clinical assistant professor at the University of Utah in the Department of Dermatology. He enjoys engaging with colleagues to discuss new developments, best practices, and challenging cases. He also contributes to a group that develops board preparation material for the American Board of Allergy and Immunology.